Suven Life sciences is a company that I am tracking from 2014 This is what I wrote in 2014 on their optionality But as you would have seen expecting the company to not to commercialize any R&D work for 18 years would be a real surprise In 2015, I noted the possibility of monetizing their lead molecule in 2017